Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse
- PMID: 12847692
- DOI: 10.1002/art.11164
Monocyte chemoattractant protein 3 as a mediator of fibrosis: Overexpression in systemic sclerosis and the type 1 tight-skin mouse
Abstract
Objective: To determine the gene-expression profile in dermal fibroblasts from type 1 tight-skin (Tsk1) mice, and to examine the expression and potential fibrotic activity of monocyte chemoattractant protein 3 (MCP-3) in Tsk1 mouse and human systemic sclerosis (SSc) skin.
Methods: Complementary DNA microarrays (Atlas 1.2) were used to compare Tsk1 fibroblasts with non-Tsk1 littermate cells at 10 days, 6 weeks, and 12 weeks of age. Expression of MCP-3 protein was assessed by Western blotting of fibroblast culture supernatants, and localized in the mouse and human skin biopsy samples by immunohistochemistry. Activation of collagen reporter genes by MCP-3 was explored in transgenic mouse fibroblasts and by transient transfection assays.
Results: MCP-3 was highly overexpressed by neonatal Tsk1 fibroblasts and by fibroblasts cultured from the lesional skin of patients with early-stage diffuse cutaneous SSc. Immunolocalization confirmed increased expression of MCP-3 in the dermis of 4 of 5 Tsk1 skin samples and 14 of 28 lesional SSc skin samples, compared with that in matched healthy mice (n = 5) and human controls (n = 11). Proalpha2(I) collagen promoter-reporter gene constructs were activated by MCP-3 in transgenic mice and by transient transfection assays. This response was maximal between 16 and 24 hours of culture and mediated via sequences within the proximal promoter. The effects of MCP-3 could be diminished by a neutralizing antibody to transforming growth factor beta.
Conclusion: We demonstrate, for the first time, overexpression of MCP-3 in early-stage SSc and in Tsk1 skin, and suggest a novel role for this protein as a fibrotic mediator activating extracellular matrix gene expression in addition to promoting leukocyte trafficking. This chemokine may be an important early member of the cytokine cascade driving the pathogenesis of SSc.
Similar articles
-
Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.Arthritis Rheum. 2004 Jan;50(1):216-26. doi: 10.1002/art.11364. Arthritis Rheum. 2004. PMID: 14730619
-
Transgenic analysis of scleroderma: understanding key pathogenic events in vivo.Autoimmun Rev. 2004 Jun;3(4):285-93. doi: 10.1016/j.autrev.2003.10.003. Autoimmun Rev. 2004. PMID: 15246024 Review.
-
Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression.Arthritis Rheum. 2001 Jun;44(6):1382-6. doi: 10.1002/1529-0131(200106)44:6<1382::AID-ART231>3.0.CO;2-T. Arthritis Rheum. 2001. PMID: 11407698
-
Activation of a fibroblast-specific enhancer of the proalpha2(I) collagen gene in tight-skin mice.Arthritis Rheum. 2001 Mar;44(3):712-22. doi: 10.1002/1529-0131(200103)44:3<712::AID-ANR121>3.0.CO;2-1. Arthritis Rheum. 2001. PMID: 11263787
-
Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis.Rheumatology (Oxford). 2009 Feb;48(2):98-103. doi: 10.1093/rheumatology/ken401. Epub 2008 Nov 4. Rheumatology (Oxford). 2009. PMID: 18984611 Review.
Cited by
-
Therapeutic targets in systemic sclerosis.Arthritis Res Ther. 2007;9 Suppl 2(Suppl 2):S6. doi: 10.1186/ar2190. Arthritis Res Ther. 2007. PMID: 17767744 Free PMC article. Review.
-
Systemic Sclerosis and the Gastrointestinal Tract-Clinical Approach.Rambam Maimonides Med J. 2016 Oct 31;7(4):e0031. doi: 10.5041/RMMJ.10258. Rambam Maimonides Med J. 2016. PMID: 27824553 Free PMC article. Review.
-
Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach.PLoS Med. 2006 Jan;3(1):e2. doi: 10.1371/journal.pmed.0030002. Epub 2005 Dec 6. PLoS Med. 2006. PMID: 16318412 Free PMC article.
-
Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects.Front Immunol. 2020 May 19;11:800. doi: 10.3389/fimmu.2020.00800. eCollection 2020. Front Immunol. 2020. PMID: 32508810 Free PMC article.
-
CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection.Front Immunol. 2019 Jan 8;9:3063. doi: 10.3389/fimmu.2018.03063. eCollection 2018. Front Immunol. 2019. PMID: 30671055 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous